These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 38749694)
21. Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status. Gevaert P; Mullol J; Saenz R; Ko J; Steinke JW; Millette LA; Meltzer EO Ann Allergy Asthma Immunol; 2024 Mar; 132(3):355-362.e1. PubMed ID: 37951571 [TBL] [Abstract][Full Text] [Related]
22. Improving predictability of IgE-high type 2 chronic sinusitis with nasal polyps in the biologic era. Heffernan A; Phulka J; Thamboo A J Otolaryngol Head Neck Surg; 2022 May; 51(1):22. PubMed ID: 35606866 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of switching between biologics in chronic rhinosinusitis with nasal polyps or N-ERD. Brkic FF; Liu DT; Klimbacher R; Campion NJ; Bartosik TJ; Vyskocil E; Stanek V; Tu A; Arnoldner T; Bangert C; Gangl K; Eckl-Dorna J; Schneider S Rhinology; 2023 Aug; 61(4):320-327. PubMed ID: 37515811 [TBL] [Abstract][Full Text] [Related]
24. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Head K; Chong LY; Hopkins C; Philpott C; Schilder AG; Burton MJ Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011992. PubMed ID: 27115214 [TBL] [Abstract][Full Text] [Related]
25. The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps. Patel GB; Peters AT Ear Nose Throat J; 2021 Jan; 100(1):44-47. PubMed ID: 33035132 [TBL] [Abstract][Full Text] [Related]
26. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study. Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399 [TBL] [Abstract][Full Text] [Related]
27. Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort. Lyly A; Genberg E; Kauppi P; Virkkula P; Lee SE; Laidlaw TM; Toppila-Salmi S; Lundberg M Int Arch Allergy Immunol; 2023; 184(2):149-160. PubMed ID: 36349770 [TBL] [Abstract][Full Text] [Related]
28. Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. De Corso E; Bellocchi G; De Benedetto M; Lombardo N; Macchi A; Malvezzi L; Motta G; Pagella F; Vicini C; Passali D Acta Otorhinolaryngol Ital; 2022 Feb; 42(1):1-16. PubMed ID: 34297014 [TBL] [Abstract][Full Text] [Related]
29. Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study. Bidder T; Sahota J; Rennie C; Lund VJ; Robinson DS; Kariyawasam HH Rhinology; 2018 Mar; 56(1):42-45. PubMed ID: 29288573 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives. Okano M; Kanai K; Oka A Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131 [TBL] [Abstract][Full Text] [Related]
31. Outcomes of dupilumab treatment versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Dharmarajan H; Falade O; Lee SE; Wang EW Int Forum Allergy Rhinol; 2022 Aug; 12(8):986-995. PubMed ID: 34919344 [TBL] [Abstract][Full Text] [Related]
32. The Efficacy of Omalizumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Comorbid Severe Allergic Asthma. Atayik E; Aytekin G; Aydin İ; Omeroglu E Iran J Allergy Asthma Immunol; 2024 May; 23(3):245-256. PubMed ID: 39422385 [TBL] [Abstract][Full Text] [Related]
33. Effects of benralizumab in a population of patients affected by severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps: a real life study. Santomasi C; Buonamico E; Dragonieri S; Iannuzzi L; Portacci A; Quaranta N; Carpagnano GE Acta Biomed; 2023 Feb; 94(1):e2023028. PubMed ID: 36786266 [TBL] [Abstract][Full Text] [Related]
34. The Effectiveness of Biological Agents on Chronic Rhinosinusitis with Nasal Polyposis in Patients with Comorbid Asthma: A Multicenter Real-Life Study from Türkiye. Demir M; Tunakan Dalgic C; Mete Gokmen EN; Savas R; Eroglu S; Ozden G; Orcen C; Pacaci Cetin G; Arslan B; Bilgir F; Bulut G; Akcam NY; Ozgul S; Cerci P; Coskun R; Gode S; Yilmaz I; Sin AZ Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541174 [No Abstract] [Full Text] [Related]
35. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Chong LY; Head K; Hopkins C; Philpott C; Schilder AG; Burton MJ Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011996. PubMed ID: 27115217 [TBL] [Abstract][Full Text] [Related]
36. Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts. Carsuzaa F; Fath L; Fieux M; Bartier S; de Bonnecaze G; Rumeau C; Michel J; Papon JF; Alexandru M; Favier V Expert Rev Clin Immunol; 2023; 19(8):1005-1011. PubMed ID: 37327360 [TBL] [Abstract][Full Text] [Related]
37. [A real world study of anti-IgE monoclonal antibody in the treatment of allergic united airway disease]. Sui HJ; Zhen Z; Wang QG; Cong TC; Huang JJ; Hu Y Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Feb; 57(2):273-280. PubMed ID: 36797588 [No Abstract] [Full Text] [Related]
39. Biologicals and Endoscopic Sinus Surgery for Severe Uncontrolled Chronic Rhinosinusitis With Nasal Polyps: An Economic Perspective. van der Lans RJL; Hopkins C; Senior BA; Lund VJ; Reitsma S J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1454-1461. PubMed ID: 35231626 [TBL] [Abstract][Full Text] [Related]
40. Which Is the Best Biologic for Nasal Polyps: Dupilumab, Omalizumab, or Mepolizumab? A Network Meta-Analysis. Wu Q; Zhang Y; Kong W; Wang X; Yuan L; Zheng R; Qiu H; Huang X; Yang Q Int Arch Allergy Immunol; 2022; 183(3):279-288. PubMed ID: 34607329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]